We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > JadiCell

News List

Therapeutic Solutions International Identifies and Files Patent on Novel Mechanism of Action of Its FDA Phase III Cleared JadiCell™ Treatment of COVID-19 and Delta Variant prnewswire
August 19, 2021
Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today novel data and filing of a patent application describing a unique mechanism of action of its JadiCell™ universal donor stem cell.
Stem cell therapy shows promise in COVID-19 respiratory distress europeanpharmaceuticalreview
May 26, 2021
JadiCell™ was shown to significantly improve survival in COVID-19 patients with Acute Respiratory Distress Syndrome (ARDS) and also reduce lung scarring associated with long-COVID-19.